Futility Study of Deferoxamine in Intracerebral Hemorrhage "DIMINIsH"

Investigator: Vineeta Singh, MD
Sponsor: Beth Israel Deaconess Medical Center

Location(s): United States


The main purpose of this study is to determine whether treatment with deferoxamine mesylate is of sufficient promise to improve outcome before pursuing a larger clinical trial to examine its effectiveness as a treatment for brain hemorrhage.